Dyne Therapeutics GAAP EPS of -$1.08 misses by $0.33 (NASDAQ:DYN)
· seekingalpha.com
Dyne Therapeutics press release (DYN): Q2 GAAP EPS of -$1.08 misses by $0.33.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...